Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical use of circulating tumor DNA analysis in patients with lymphoma

2 Nov 2024

Abstract excerpt

The analysis of circulating tumor DNA (ctDNA) in liquid biopsy specimens has an established role for the detection of predictive molecular alterations and acquired resistance mutations in several tumors. The low-invasiveness of this approach allows for repeated sampling and dynamic monitoring of disease evolution. Originating from the entire body tumor bulk, plasma-derived ctDNA reflects intra- and interlesional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genetic factors in colorectal cancer
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39491629
DOI: 10.1016/j.humpath.2024.105679

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical use of circulating tumor DNA analysis in patients with lymphomaPMID 39491629Read ↗

Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational researchSemantic proximity Read ↗

Circulating tumor DNA as a powerful tool in diagnostics and treatment outcome prediction - focus on large B-cell lymphomas and follicular lymphomas.Semantic proximity Read ↗

Circulating Tumor DNA in Lymphoma.Semantic proximity Read ↗

Circulating Tumor DNA in Lymphoma: Principles and Future DirectionsSemantic proximity Read ↗

[Progression and application of circulating tumor DNA in lymphoma].Semantic proximity Read ↗

Circulating tumour DNA in B‐cell lymphomas: current state and future prospectsSemantic proximity Read ↗

Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.Semantic proximity Read ↗

Circulating Tumor DNA Reflects Histologic and Clinical Characteristics of Various Lymphoma Subtypes.Semantic proximity Read ↗

Liquid biopsy in lymphoma: Molecular methods and clinical applications.Semantic proximity Read ↗

The future of cell-free DNA testing to guide therapeutic decisions in B-cell lymphomasSemantic proximity Read ↗

The value of liquid biopsy in diagnosis and monitoring of diffuse large b-cell lymphoma: recent developments and future potential.Semantic proximity Read ↗

Toward liquid biopsies in cancer treatment: application of circulating tumor DNASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.